First-line protocol
Treatment of Chronic Venous Insufficiency with Symptomatic Great Saphenous Vein Reflux
This protocol applies to adults with symptomatic great saphenous vein (GSV) reflux — including those with concurrent small saphenous vein (SSV) reflux — as the primary clinical presentation of chronic venous disease.
Clinical Scenario
The target population is adults with documented symptomatic GSV reflux, with or without associated SSV reflux. Clinical guideline recommendations specifically address this sub-population, distinguishing management from broader or undifferentiated chronic venous disease.
Treatment Approach
Initial management is built around conservative therapy. The full protocol specifies which measures are included and the conditions under which further intervention becomes appropriate — details available via the structured regimen below.
Clinical Goals
- Reduced leg discomfort
- Reduced volume of edema
References
DOI: 10.1016/j.jscai.2025.103729
For patients with symptomatic GSV with or without SSV reflux, the SCAI guideline panel suggests ablation therapy plus conservative management rather than conservative management alone (conditional recommendation, low certainty of evidence).
The first line of treatment for CVD is conservative therapy, which generally includes compression therapy, venotonic medications, lifestyle changes, weight loss if applicable, and wound care for patients with ulcerative disease.
Patients with ulcer disease are more likely to benefit from ablative therapy upfront, while others should generally consider an initial course of conservative management with compression therapy.
In patients with symptomatic varicose veins, compression may reduce discomfort (standard mean difference, 0.68; 95% CI, 0.87-0.49), which studies measured using a numerical rating scale from 0 or 1 (least pain) to 10 (most pain).
View source ↗